Ginkgo Bioworks Holdings (DNA) Total Non-Current Liabilities (2020 - 2025)

Ginkgo Bioworks Holdings filings provide 6 years of Total Non-Current Liabilities readings, the most recent being $588.2 million for Q4 2025.

  • On a quarterly basis, Total Non-Current Liabilities fell 8.78% to $588.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $588.2 million, a 8.78% decrease, with the full-year FY2025 number at $588.2 million, down 8.78% from a year prior.
  • Total Non-Current Liabilities hit $588.2 million in Q4 2025 for Ginkgo Bioworks Holdings, down from $612.2 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $780.3 million in Q1 2023 to a low of $61.8 million in Q1 2021.
  • Median Total Non-Current Liabilities over the past 5 years was $594.2 million (2025), compared with a mean of $540.2 million.
  • Biggest five-year swings in Total Non-Current Liabilities: surged 535.75% in 2022 and later dropped 29.55% in 2023.
  • Ginkgo Bioworks Holdings' Total Non-Current Liabilities stood at $467.6 million in 2021, then soared by 65.06% to $771.9 million in 2022, then dropped by 29.55% to $543.8 million in 2023, then increased by 18.59% to $644.8 million in 2024, then dropped by 8.78% to $588.2 million in 2025.
  • The last three reported values for Total Non-Current Liabilities were $588.2 million (Q4 2025), $612.2 million (Q3 2025), and $600.1 million (Q2 2025) per Business Quant data.